Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christos Hatzis

Showing results (41-50 of 99) with videos related to

Pageof 10
Sort By:
Anticancer Research|April 9, 2013
Adipose tissue fatty acid composition in Greek patients with breast cancer versus those with benign breast tumorsEelco De Bree, George Mamalakis, Elias Sanidas, et al.
Breast Cancer Research : BCR|July 31, 2016
Quantitative assessment of the spatial heterogeneity of tumor-infiltrating lymphocytes in breast cancerNikita L Mani, Kurt A Schalper, Christos Hatzis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Microtubule-associated protein-tau is a bifunctional predictor of endocrine sensitivity and chemotherapy resistance in estrogen receptor-positive breast cancerFabrice Andre, Christos Hatzis, Keith Anderson, et al.
Pharmacology, Biochemistry, and Behavior|November 21, 2007
Lack of an association of depression with n-3 polyunsaturated fatty acids in adipose tissue and serum phospholipids in healthy adultsGeorge Mamalakis, Michael Kiriakakis, George Tsibinos, et al.
Scientific Reports|October 19, 2019
Identification and Validation of a Novel Biologics Target in Triple Negative Breast CancerVikram B Wali, Gauri A Patwardhan, Vasiliki Pelekanou, et al.
Journal of the National Cancer Institute. Monographs|June 12, 2015
Neoadjuvant Model in Cancer Treatment: From Clinical Opportunity to Health-Care UtilityDaniele Generali, Stephen B Fox, Massimo Cristofanilli, et al.
Molecular Cancer Therapeutics|April 29, 2010
Development of candidate genomic markers to select breast cancer patients for dasatinib therapyStacy Moulder, Kai Yan, Fei Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 11, 2020
Analysis of Pre- and Posttreatment Tissues from the SWOG S0800 Trial Reveals an Effect of Neoadjuvant Chemotherapy on the Breast Cancer GenomeRyan L Powles, Vikram B Wali, Xiaotong Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2016
T-DM1 Activity in Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancers That Received Prior Therapy With Trastuzumab and PertuzumabHannah Dzimitrowicz, Michael Berger, Craig Vargo, et al.
Breast Cancer Research and Treatment|February 18, 2015
Sirolimus and trastuzumab combination therapy for HER2-positive metastatic breast cancer after progression on prior trastuzumab therapyCarlos Acevedo-Gadea, Christos Hatzis, Gina Chung, et al.
Pageof 10

Showing results (41-50 of 99) with videos related to

Sort By:
Pageof 10
Anticancer Research|April 9, 2013
Adipose tissue fatty acid composition in Greek patients with breast cancer versus those with benign breast tumorsEelco De Bree, George Mamalakis, Elias Sanidas, et al.
Breast Cancer Research : BCR|July 31, 2016
Quantitative assessment of the spatial heterogeneity of tumor-infiltrating lymphocytes in breast cancerNikita L Mani, Kurt A Schalper, Christos Hatzis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Microtubule-associated protein-tau is a bifunctional predictor of endocrine sensitivity and chemotherapy resistance in estrogen receptor-positive breast cancerFabrice Andre, Christos Hatzis, Keith Anderson, et al.
Pharmacology, Biochemistry, and Behavior|November 21, 2007
Lack of an association of depression with n-3 polyunsaturated fatty acids in adipose tissue and serum phospholipids in healthy adultsGeorge Mamalakis, Michael Kiriakakis, George Tsibinos, et al.
Scientific Reports|October 19, 2019
Identification and Validation of a Novel Biologics Target in Triple Negative Breast CancerVikram B Wali, Gauri A Patwardhan, Vasiliki Pelekanou, et al.
Journal of the National Cancer Institute. Monographs|June 12, 2015
Neoadjuvant Model in Cancer Treatment: From Clinical Opportunity to Health-Care UtilityDaniele Generali, Stephen B Fox, Massimo Cristofanilli, et al.
Molecular Cancer Therapeutics|April 29, 2010
Development of candidate genomic markers to select breast cancer patients for dasatinib therapyStacy Moulder, Kai Yan, Fei Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 11, 2020
Analysis of Pre- and Posttreatment Tissues from the SWOG S0800 Trial Reveals an Effect of Neoadjuvant Chemotherapy on the Breast Cancer GenomeRyan L Powles, Vikram B Wali, Xiaotong Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2016
T-DM1 Activity in Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancers That Received Prior Therapy With Trastuzumab and PertuzumabHannah Dzimitrowicz, Michael Berger, Craig Vargo, et al.
Breast Cancer Research and Treatment|February 18, 2015
Sirolimus and trastuzumab combination therapy for HER2-positive metastatic breast cancer after progression on prior trastuzumab therapyCarlos Acevedo-Gadea, Christos Hatzis, Gina Chung, et al.
Pageof 10